Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival

Sung W. Choi, Carrie L. Kitko, Thomas Braun, Sophie Paczesny, Gregory Yanik, Shin Mineishi, Oleg Krijanovski, Dawn Jones, Joel Whitfield, Kenneth Cooke, Raymond J. Hutchinson, James L.M. Ferrara, John E. Levine

Research output: Contribution to journalArticle

89 Citations (Scopus)

Abstract

Acute graft-versus-host disease (GVHD) remains a significant cause of mortality after hematopoietic cell transplantation (HCT). Tumor necrosis factor-alpha (TNF-α) mediates GVHD by amplifying donor immune responses to host tissues and by direct toxicity to target organs.We measured TNF receptor 1 (TNFR1) as a surrogate marker for TNF-α in 438 recipients of myeloablative HCT before transplantation and at day 7 after transplantation. Increases in TNFR1 levels more than or equal to 2.5 baseline correlated with eventual development of GVHD grade 2 to 4 (58% vs 32%, P <.001) and with treatment-related mortality (39% vs 17%, P <.001). In a multivariate analysis including age, degree of HLA match, donor type, recipient and donor sex, disease, and status at HCT, the increase in TNFR1 level at day 7 remained a significant predictor for outcome. Measurement of TNFR1 levels early after transplantation provides independent information in advance of important clinical outcomes, such as GVHD and death.

Original languageEnglish (US)
Pages (from-to)1539-1542
Number of pages4
JournalBlood
Volume112
Issue number4
DOIs
StatePublished - Aug 15 2008

Fingerprint

Transplantation (surgical)
Tumor Necrosis Factor Receptors
Homologous Transplantation
Graft vs Host Disease
Grafts
Cell Transplantation
Plasmas
Transplantation
Incidence
Tumor Necrosis Factor-alpha
Mortality
Multivariate Analysis
Biomarkers
Toxicity
Tissue

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Cite this

Choi, Sung W. ; Kitko, Carrie L. ; Braun, Thomas ; Paczesny, Sophie ; Yanik, Gregory ; Mineishi, Shin ; Krijanovski, Oleg ; Jones, Dawn ; Whitfield, Joel ; Cooke, Kenneth ; Hutchinson, Raymond J. ; Ferrara, James L.M. ; Levine, John E. / Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival. In: Blood. 2008 ; Vol. 112, No. 4. pp. 1539-1542.
@article{c0a9365754d24c4cbb327b64b6dfd552,
title = "Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival",
abstract = "Acute graft-versus-host disease (GVHD) remains a significant cause of mortality after hematopoietic cell transplantation (HCT). Tumor necrosis factor-alpha (TNF-α) mediates GVHD by amplifying donor immune responses to host tissues and by direct toxicity to target organs.We measured TNF receptor 1 (TNFR1) as a surrogate marker for TNF-α in 438 recipients of myeloablative HCT before transplantation and at day 7 after transplantation. Increases in TNFR1 levels more than or equal to 2.5 baseline correlated with eventual development of GVHD grade 2 to 4 (58{\%} vs 32{\%}, P <.001) and with treatment-related mortality (39{\%} vs 17{\%}, P <.001). In a multivariate analysis including age, degree of HLA match, donor type, recipient and donor sex, disease, and status at HCT, the increase in TNFR1 level at day 7 remained a significant predictor for outcome. Measurement of TNFR1 levels early after transplantation provides independent information in advance of important clinical outcomes, such as GVHD and death.",
author = "Choi, {Sung W.} and Kitko, {Carrie L.} and Thomas Braun and Sophie Paczesny and Gregory Yanik and Shin Mineishi and Oleg Krijanovski and Dawn Jones and Joel Whitfield and Kenneth Cooke and Hutchinson, {Raymond J.} and Ferrara, {James L.M.} and Levine, {John E.}",
year = "2008",
month = "8",
day = "15",
doi = "10.1182/blood-2008-02-138867",
language = "English (US)",
volume = "112",
pages = "1539--1542",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "4",

}

Choi, SW, Kitko, CL, Braun, T, Paczesny, S, Yanik, G, Mineishi, S, Krijanovski, O, Jones, D, Whitfield, J, Cooke, K, Hutchinson, RJ, Ferrara, JLM & Levine, JE 2008, 'Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival', Blood, vol. 112, no. 4, pp. 1539-1542. https://doi.org/10.1182/blood-2008-02-138867

Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival. / Choi, Sung W.; Kitko, Carrie L.; Braun, Thomas; Paczesny, Sophie; Yanik, Gregory; Mineishi, Shin; Krijanovski, Oleg; Jones, Dawn; Whitfield, Joel; Cooke, Kenneth; Hutchinson, Raymond J.; Ferrara, James L.M.; Levine, John E.

In: Blood, Vol. 112, No. 4, 15.08.2008, p. 1539-1542.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival

AU - Choi, Sung W.

AU - Kitko, Carrie L.

AU - Braun, Thomas

AU - Paczesny, Sophie

AU - Yanik, Gregory

AU - Mineishi, Shin

AU - Krijanovski, Oleg

AU - Jones, Dawn

AU - Whitfield, Joel

AU - Cooke, Kenneth

AU - Hutchinson, Raymond J.

AU - Ferrara, James L.M.

AU - Levine, John E.

PY - 2008/8/15

Y1 - 2008/8/15

N2 - Acute graft-versus-host disease (GVHD) remains a significant cause of mortality after hematopoietic cell transplantation (HCT). Tumor necrosis factor-alpha (TNF-α) mediates GVHD by amplifying donor immune responses to host tissues and by direct toxicity to target organs.We measured TNF receptor 1 (TNFR1) as a surrogate marker for TNF-α in 438 recipients of myeloablative HCT before transplantation and at day 7 after transplantation. Increases in TNFR1 levels more than or equal to 2.5 baseline correlated with eventual development of GVHD grade 2 to 4 (58% vs 32%, P <.001) and with treatment-related mortality (39% vs 17%, P <.001). In a multivariate analysis including age, degree of HLA match, donor type, recipient and donor sex, disease, and status at HCT, the increase in TNFR1 level at day 7 remained a significant predictor for outcome. Measurement of TNFR1 levels early after transplantation provides independent information in advance of important clinical outcomes, such as GVHD and death.

AB - Acute graft-versus-host disease (GVHD) remains a significant cause of mortality after hematopoietic cell transplantation (HCT). Tumor necrosis factor-alpha (TNF-α) mediates GVHD by amplifying donor immune responses to host tissues and by direct toxicity to target organs.We measured TNF receptor 1 (TNFR1) as a surrogate marker for TNF-α in 438 recipients of myeloablative HCT before transplantation and at day 7 after transplantation. Increases in TNFR1 levels more than or equal to 2.5 baseline correlated with eventual development of GVHD grade 2 to 4 (58% vs 32%, P <.001) and with treatment-related mortality (39% vs 17%, P <.001). In a multivariate analysis including age, degree of HLA match, donor type, recipient and donor sex, disease, and status at HCT, the increase in TNFR1 level at day 7 remained a significant predictor for outcome. Measurement of TNFR1 levels early after transplantation provides independent information in advance of important clinical outcomes, such as GVHD and death.

UR - http://www.scopus.com/inward/record.url?scp=51649121552&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=51649121552&partnerID=8YFLogxK

U2 - 10.1182/blood-2008-02-138867

DO - 10.1182/blood-2008-02-138867

M3 - Article

C2 - 18502834

AN - SCOPUS:51649121552

VL - 112

SP - 1539

EP - 1542

JO - Blood

JF - Blood

SN - 0006-4971

IS - 4

ER -